Both EGFR and HER2 were also highly expressed in MCF7/ER36 cells (Figure 3D), indicating that increased ER-α36 expression is one of the mechanisms by which ER-positive breast cancer cells gained EGFR and HER2 expression. This evidence concerns the gene ERBB2 and breast carcinoma.